This is the authors' abstract. We don't add key points for this paper.
Polypharmacy as consequence of multimorbidity remains to be a challenging problem in older adults [ 1 , 2 ] and effective preventive measures need to be implemented into clinical practice [ 3 , 4 , 5 ]. The appropriateness of the necessary drugs should be reviewed by the critical evaluation of pharmacotherapy in older individuals on a regular base (medication review) [ 6 ]. The Fit for the Aged (FORTA) List addresses both over- and undertreatment leading to a comprehensive dealing with patients’ medical needs [ 6 ].
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Pazan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: